| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3d7e2f8fb5650d7d3616661464b67771 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-475
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4745 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709 |
| filingDate |
2020-04-20^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6a778a430d65f552ac73968079762cf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4d12cf202769cc45448960d3614c782
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89ab9a631699e7497db53e1b6ec48e99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eeb1bef21626a7e7a93fbbf86de0b253
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3e70701ee34f97020b235c4955e7cf7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66d5eacaeee0be201f472043e39dce76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af1f8aba81b23a312c9edb3207465348
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_018f9eaecf8fa17bdedd846a0d5de53f |
| publicationDate |
2021-12-02^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2020259565-A1 |
| titleOfInvention |
Quinoline compound or pharmaceutically acceptable salt thereof for treating Ewing's sarcoma |
| abstract |
The present invention belongs to the field of medicine, and provides a quinoline compound or a pharmaceutically acceptable salt thereof for treating Ewing's sarcoma, and particularly relates to use of compound I or a pharmaceutically acceptable salt thereof in the preparation of a medicament for treating Ewing's sarcoma and use of compound I or a pharmaceutically acceptable salt thereof in combination with a second therapeutic agent in the preparation of a combination medicament for treating Ewing's sarcoma. The chemical name of compound I is 1-[[[4-(4-fluoro-2-methyl-1H-indol-5-yl)oxy-6-methoxyquinolin-7-yl]oxy]methyl]cyclopropanamine. |
| priorityDate |
2019-04-19^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |